Q&A
UK cell and gene therapy ecosystem ‘second to none’
The UK has a ‘rich and vibrant’ advanced therapeutic manufacturing sector well placed to attract companies post-Brexit, says Keith Thompson, CEO of CGTC.
Archives for November 26, 2018
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs